NanoViricides Cash Flow Statement

Financials in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Year	2023	2022	2021	2020	2019	2018 - 2006
Net Income	-8.59	-8.11	-8.82	-13.45	-8.42	Upgrade
Depreciation & Amortization	0.75	0.72	0.7	0.7	0.7	Upgrade
Share-Based Compensation	0	0	0	0	0.01	Upgrade
Other Operating Activities	2.17	1.49	-0.1	6.08	0.91	Upgrade
Operating Cash Flow	-5.67	-5.89	-8.21	-6.67	-6.8	Upgrade
Capital Expenditures	-0.15	-0.32	-0.24	-0.01	-0.07	Upgrade
Investing Cash Flow	-0.15	-0.32	-0.24	-0.01	-0.07	Upgrade
Share Issuance / Repurchase	0	0	16.56	16.68	2.35	Upgrade
Debt Issued / Paid	-0.09	-0.23	-1.3	1.16	0	Upgrade
Other Financing Activities	-	-	-	-0.01	-	Upgrade
Financing Cash Flow	-0.09	-0.23	15.26	17.83	2.35	Upgrade
Net Cash Flow	-5.92	-6.45	6.81	11.15	-4.53	Upgrade
Free Cash Flow	-5.82	-6.22	-8.45	-6.67	-6.88	Upgrade
Free Cash Flow Per Share	-0.50	-0.54	-0.78	-1.19	-1.92	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).